Can Red Light Therapy Reduce Cancer Risk?

Red Light Therapy (RLT), also known as photobiomodulation, is rapidly gaining recognition as a promising tool in the wellness industry. But could this technology, which harnesses red and near-infrared light, also help reduce your cancer risk? Recent scientific findings suggest the answer could be yes.

For more insights, check out our podcast on Red Light Therapy here on Spotify.

How Red Light Therapy Enhances Cellular Energy

At the heart of Red Light Therapy’s benefits is its unique ability to improve oxygen utilization within cells, specifically in mitochondria—the powerhouse of our cells. Using specific wavelengths (typically 600–1000 nm), RLT stimulates the activity of cytochrome c oxidase (CcO), a crucial enzyme involved in the mitochondrial electron transport chain.

Normally, nitric oxide (NO) binds to CcO, limiting oxygen’s effectiveness in cellular energy production. Red Light Therapy effectively releases nitric oxide from CcO, enhancing oxygen participation in oxidative phosphorylation. This shift significantly boosts ATP production—delivering up to 32 ATP molecules per glucose molecule, compared to just 2 ATP via anaerobic glycolysis.

This effect has been well-documented in studies like those from Hamblin et al. (2016), highlighting how RLT not only enhances mitochondrial efficiency but also significantly increases ATP production.

The Connection: Red Light Therapy and the Warburg Effect

To understand the cancer-prevention potential of RLT, we revisit a landmark discovery by Nobel laureate Otto Warburg. Warburg identified a unique characteristic of cancer cells—they prefer anaerobic metabolism (glycolysis) even when sufficient oxygen is present, known as the “Warburg Effect.” This metabolic shift, characterized by impaired mitochondrial respiration, allows cancer cells to proliferate rapidly despite their energy inefficiency.

Given RLT’s capacity to restore mitochondrial oxygen utilization and favor aerobic respiration, it could theoretically reduce the cellular environment that fosters cancer growth. Although direct evidence from large clinical trials is not yet available, preliminary studies (e.g., de Freitas & Hamblin, 2016) suggest photobiomodulation supports mitochondrial health, reduces oxidative stress, and decreases inflammation—all critical factors associated with cancer prevention.

Real-world Applications of Red Light Therapy

Devices such as the Naviocean Red Light Therapy Arm Belt, combining 660nm red and 850nm near-infrared wavelengths, have shown remarkable promise for at-home therapy. Frequency Research Foundation’s testing revealed this small device offered energy enhancements typically observed in larger, professional-grade systems. Users report significant pain relief, improved joint and muscle recovery, and overall better well-being.

Tests indicate these affordable and portable pads penetrate effectively up to 40mm beneath the skin’s surface, proving that targeted frequency exposure can efficiently replicate broader clinical benefits at home.

Real-World Results and Practical Applications

Beyond theoretical benefits, RLT has practical, tangible impacts. In tests conducted by Frequency Research Foundation, users demonstrated measurable increases in mitochondrial energy production. Analytics consistently showed cells shifting from anaerobic to aerobic metabolism, reflecting significantly enhanced oxygen utilization.

Notably, a recent 2024 study published in the Journal of Biophotonics supports these claims, documenting improvements in mitochondrial performance and overall cell vitality with regular red light exposure.

How to Incorporate Red Light Therapy in Your Routine

RLT is accessible and practical for daily use, with devices available for targeted treatment or full-body rejuvenation. Products like Naviocean’s therapy pads offer affordable, effective at-home treatments, enhancing cellular health and potentially reducing inflammation and stress.

Frequency Foundation’s research suggests an immediate boost in bodily energy following sessions, with sustained benefits throughout the day, corroborated by wearable health technology data such as Garmin’s Firstbeat analytics.

Recommended Red Light Therapy Devices

Selecting the right Red Light Therapy (RLT) device depends on your personal needs, budget, and therapeutic goals. Here are two excellent options recommended by Frequency Research Foundation:

Naviocean Infrared Red Light Therapy Arm Belt
Type: Affordable, targeted treatment
Features: Compact design, targeted pain relief using 660nm red and 850nm near-infrared light, adjustable brightness and timer settings, suitable for localized applications such as joints, muscles, and smaller body areas. Portable and compatible with power banks for convenience.
Price: Approximately $74 on Amazon.
Joovv Solo 3.0
Type: Premium, full-body therapy
Features: Full-body, medical-grade red light therapy device, expandable system, modular design, providing comprehensive red and near-infrared light treatment suitable for extensive therapeutic benefits.
Price: Approximately $1,699, designed for home use with medical-grade results.

Select the device best suited to your specific needs—Naviocean for targeted relief on a budget, or Joovv Solo 3.0 for premium, full-body therapeutic benefits.

Take Action Today for Your Health and Longevity

The evidence continues to grow, suggesting Red Light Therapy could be a powerful tool not only for enhancing your daily health but potentially reducing long-term cancer risks by addressing the cellular dysfunction identified decades ago by Otto Warburg.

The anerobic, glucose driven, mitochondria energy cycle is at the root of most chronic diseases including diabetes, cancer, and mental problems. The value of red light therapy (with the right devices) is pushing the mitochondia into the aerobic cycle. Our applied kinestheiology tests indicate this can double your energy level in one session. This effect can be measured by Body Battery on the Garmin watch. A high Body Battery over 80 in the morning can be kept as high as 70 by 10pm at night by a practitioner of the TEHS Scrum Framework for Health and Performance, a result never seen before red light therapy.

Interested in taking the next step?

📞 Contact us to learn more or get personalized recommendations

🔗 Explore the benefits and start your journey to enhanced wellness and longevity.

Optune Lua Harnesses Frequencies to Revolutionize Cancer Care

Advancements in cancer treatment are taking an extraordinary leap forward with Novocure’s Optune Lua, a wearable device recently approved by the FDA for treating metastatic non-small cell lung cancer (NSCLC). Optune Lua employs Tumor Treating Fields (TTFields)—carefully tuned electric frequencies—to disrupt cancer cell division, providing a cutting-edge, non-invasive approach to cancer care. Learn more about how this is changing the landscape of cancer treatment on Novocure’s official Optune Lua page.

How Tumor Treating Fields Work

Optune Lua harnesses the power of Tumor Treating Fields (TTFields), which are precisely tuned alternating electric frequencies that target dividing cancer cells. These fields specifically interfere with the microtubules essential for mitosis, disrupting the normal division process and leading to the death of rapidly dividing cancer cells. By focusing on these cancerous cells, TTFields minimize damage to surrounding healthy tissues, exemplifying the precision of frequency-based therapy. Watch Novocure’s explanation of how TTFields work across multiple mechanisms.

Redefining Survival with Complementary Treatment

Optune Lua seamlessly integrates with existing cancer therapies. Combined with PD-1/PD-L1 inhibitors or chemotherapy drugs like docetaxel, this device improves survival rates for NSCLC patients. In the pivotal Phase 3 LUNAR study, patients using Optune Lua alongside immunotherapy experienced an 8-month increase in median survival. When paired with chemotherapy, the device added 2.2 months to patient outcomes.

The Power of Frequencies in Non-Invasive Treatment

Optune Lua represents a unique application of frequency technology to transform patient care. Frequencies, when harnessed correctly, can achieve precise, targeted results. Like many innovative tools that rely on frequency-based mechanisms to solve complex problems, Optune Lua shows how subtle forces can deliver profound impact.

The device’s non-invasive nature makes it an appealing alternative to traditional treatments like surgery or radiation. Patients can carry on their daily lives while undergoing continuous therapy, experiencing fewer systemic side effects. The most common adverse effect—mild skin irritation at electrode sites—is generally manageable, making Optune Lua a patient-friendly option.

A Future Fueled by Innovation

The success of Optune Lua marks a turning point in oncology, with its technology poised to expand beyond lung cancer to other challenging diagnoses. By integrating frequencies into patient care, this groundbreaking device highlights the limitless potential of this innovative approach. This innovative use of frequencies illustrates a broader trend in medicine, where subtle, controlled energy forms are being leveraged to address complex health challenges. As research in frequency therapy advances, it enhances cancer care and paves the way for novel treatments across various diseases.

Linking with Frequency Research Foundation’s Innovations

At the Frequency Research Foundation, we harness frequency technology for innovative solutions to complex diseases. Our approach not only enhances traditional treatment methods but also provides patients with less invasive and more personalized care options.

Explore how frequency therapy can revolutionize your treatment options. Book a consultation today to learn more about personalized care at the Frequency Research Foundation. Don’t miss our latest podcast on the future of frequency therapies: Listen on Spotify.

Anthony Holland’s Magic Frequency

Mercury and Lead are Toxic – Add Flouride to the List

Moms2B Avoid Fluoride

During pregnancy Moms know to protect their babies by avoiding

smoking

alcohol

medications

raw meat and seafood

high-mercury fish
AND NOW WE SHOULD ADD

fluoride in water, food, and drinks

Why add fluoride to the list?

In 2017, a 12-year-long government-funded study was completed. It showed significant reductions in children’s IQ when their mothers were exposed to fluoride during pregnancy. In this carefully-controlled study of Mexican mother-offspring pairs by American and Canadian researchers, mothers were receiving the same fluoride doses as mothers in the US who live in communities that add fluoride dental treatment to their water.

What should pregnant women know about this study?

The results of the 2017 study by Bashash et al. included up to 299 pregnant women and their offspring. Fluoride exposure was determined by measuring fluoride in the urine of the pregnant women because that is a very reliable measure of total fluoride exposure. The researchers found a correlation between the urine fluoride of the pregnant mothers and a loss of up to 6 IQ points in their children when the children were tested at age 4 and again between 6-12 years of age. This study was published in the journal Environmental Health Perspectives in September 2017.

Is there another mother-offspring study?

Yes, a second study by Thomas et al. was presented at a conference in March 2018. The researchers reported lower IQ scores due to prenatal fluoride exposure when the children were tested between the ages of 1 and 3.

Is this new information?

Yes. While there are another 53 published studies reporting an association of fluoride exposure with a lowering of IQ in children, and over 200 animal-fluoride studies reporting damage to the brain and reduced learning and memory ability, the surprise came with the release of these mother-offspring fluoride studies. Why? Because they have clearly demonstrated, for the first time, that pregnancy is the most critical period for exposure to fluoride. The fetus now ranks as the most vulnerable of our species to fluoride’s toxicity.

Pregnant women should know about these studies in order to take the necessary steps to protect their child’s brain.

Who funded these studies?

The two mother-offspring studies were funded by the U.S. National Institutes of Health, the U.S. Environmental Protection Agency, and the U.S. National Institute of Environmental Health Sciences.

For more info on these studies use the links
in the Select-a-Topic at the top

How is a pregnant woman exposed to fluoride?

Fluoride is added to approximately 70% of public drinking water systems across the U.S. as non-consensual dental treatment. Exposure to fluoride mainly occurs by ingestion or inhalation. The greatest exposure to fluoride for the majority of Americans comes from drinking fluoridated water and using it in food preparation to make soups, rice, coffee, tea, infant formula, etc. Fluoride also has many industrial uses, so living close to a fluoride/fluorine emitting industry is also a concern. For more information on industrial releases, see the EPA’s Toxic Release Inventory for fluorides.

What water should I drink if I am pregnant? — Find out here

Questions & Concerns? Check out the Q & A

Pseudoscience: Monsanto’s ghostwriting and strong-arming threaten sound science—and society

While passing a placard of contemporary protest buttons in New York’s Greenwich Village, my attention was drawn to one that read “Science is Peer Reviewed, Not Politician Approved.”

This short aphorism brought into focus two unfortunate realities. First, there are growing segments of the population who have lost confidence in science and choose to act on un-scientific or pseudo-scientific truth claims. And second, other segments of the population view scientists as just another stakeholder group subject to the same market influences in the competition for producing credible knowledge.

As a generator of truth claims, science stands on its own footing. Unfortunately, many corporations view science not as a generator of truth, but as one of many inputs into production.

The most recent examples of the corporate capture of science can be found in the investigations of discovery documents, released under court mandate, arising from mass tort product liability litigation filed against Monsanto Co. Thousands of people have filed lawsuits claiming they developed cancer after exposure to the company’s Roundup herbicide, and that the company suppressed information about the toxic effects of Roundup.

Thousands of pages of these discovery documents – made up largely of internal Monsanto communications – were analyzed in two peer-reviewed publications. My co-author Carey Gillam and I published our results in the Journal of Public Health Policy. Leemon McHenry, a member of the Philosophy Department at California State University, published his assessment in the International Journal of Risk & Safety in Medicine.

Pseudoscience: Most Published Research Cannot be Replicated

Occasionally big pharma provides really useful results. Checking on which studies are valid by trying to replicate them in order to search for new drugs shows most published research is nonsense.

How Reliable Are Cancer Studies?

Atlantic Magazine, Ed Yong, 18 Jan 2017

A project that tried to reproduce the results of 50 landmark papers turned into an arduous slog—and that’s a problem in itself.

In recent years, scientists have been dealing with concerns about a reproducibility crisis—the possibility that many published findings may not actually be true. Psychologists have grappled intensively with this problem, trying to assess its scope and look for solutions. And two reports from pharmaceutical companies have suggested that cancer biologists have to face a similar reckoning.

In 2011, Bayer Healthcare said that its in-house scientists could only validate 25 percent of basic studies in cancer and other conditions. (Drug companies routinely do such checks so they can use the information in those studies as a starting point for developing new drugs.) A year later, Glenn Begley and Lee Ellis from Amgen said that the firm could only confirm the findings in 6 out of 53 landmark cancer papers—just 11 percent. Perhaps, they wrote, that might explain why “our ability to translate cancer research to clinical success has been remarkably low.”

Biofilms Version 7.0

Biofilms – Version 7.0 is the 1917 release of hundreds of biofilm programs. Thousands of updates and many more bacterial strains have been added. Use of the new Hunter 4025 scanning technology has allowed more precise identification of specific pathogens in some cases.

Most of the 600 strains of periodontal biofilms DNA sequenced by the National Institutes of Health are now in this series of programs. Most strains of lyme disease borrelia are included. Nanobacteria and other biofilms associated with Altzheimers can be found here. Biofilms are associated with all major disease categories. There is even a new program targets abdominal fat.

Recent research has focused on biofilm involvement in tumors. All tumors (benign and malignant) are infected with biofilms. The relationship of causation of tumors by biofilms is still being researched. It appears that many so-called Rife frequencies are really components of biofilms.

There is extensive academic research on biofilms. See Montana State University Center for Biofilm Engineering for the basics, as well as access to papers from dozens of conferences. For example, most people have biofilms forming calcification in their joints and articles. Here is a photo of such a biofilm on a grain of sand:

These biofioms are not doing your heart any good.

Most bacteria infections today are antibiotic resistant biofilms. While over 600 species of these biofilms have been DNA sequenced for periodontal disease, these gum infections are the tip of the iceberg. A huge amount of illness from joint problems to wound infections to heart disease are caused by biofilms.

During the past two years, intensive research at the Frequency Research Foundation has developed frequency sequences for about 400 biofilms. A notable finding is that radical reduction in blood pressure can be achieved by running the appropriate borrelia biofilm programs for infected individuals. All people exposed to lyme disease will need them.

Chronic Periodontitis: Geographic Differences in the Oral Biofilm

January 2005, National Institute of Dental and Craniofacial Research

It has long been assumed that all chronic periodontitis is the same no matter where one lives in the world. But some scientists have wondered whether the bacterial composition of the oral biofilm – the sticky, mat-like microbial communities that form on our teeth and cause chronic periodontitis – might vary geographically. In the November issue of the Journal of Clinical Periodontology, NIDCR grantees and their colleagues report for the first time that this is indeed the case. In a study of more than 300 patients with chronic periodontitis from Sweden, the United States, Brazil, and Chile, they found clear geographical differences in the bacterial content of dental plaque obtained from the periodontal lesions. To hear more about this important paper, the Inside Scoop recently talked with lead author Anne Haffajee, B.D.S., and Sigmund Socransky, D.D.S., the senior author. Both are scientists at The Forsyth Institute in Boston.

—–

Work on biofilms is becoming as extensive as previous work on lyme disease frequencies. Daily updates indicate that they are at the root of much of heart disease, respiratory problems, joint issues, prostate problems, and tumors of all types. Recent releases added many biofilms seen with abnormal cells in cancer patients, raising the question as to whether they are involved in carcinogenesis.

There are over 600 species of periodontal biofilms that have been DNA sequenced. During the past two years, the Frequency Research Foundation has expanded detailed analysis of frequencies for many more biofilm infections. This is the most extensive research effort since development of the lyme disease frequency sets and has involved daily analysis and update of biofilm frequencies from September 2011 until July 2013. As a result these data are the most comprehensive biofilm frequency sets available.

Some are based on the lyme borellia spirochete and cause elevated blood pressure. Others are directly related to mortality from heart disease.

See:

Am J Pathol. 2007 Jan;170(1):33-42.

Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarction.

Spagnoli LG, Pucci S, Bonanno E, Cassone A, Sesti F, Ciervo A, Mauriello A.

All biofilms can go systemic in the body and cause a wide variety of symptoms and disease outcomes. For the first time it is possible to work on getting rid of the root cause of gum disease and other persistent infections.

Frequencies are published as a set of over a dozen F165 program files. It is best to work on one biofilm frequency set at a time as one clinician has noted that use of these frequencies is analogous to tearing up the floorboards in your house. You never know what you are going to find underneath.

Biofilm frequencies are available to subscribers.

SV40 Virus Frequencies

Recent work on multiple cases of SV40 with related cancers led to significant updates to multiple strains of the virus using the latest frequency templates. Each virus strain has over two dozen frequencies which target the virus, all of the components of the machinery for the virus, the DNA of cells contaminated with the virus, and the energy system of the human body which is distorted by the virus. All frequencies are available to subscribers.

[trx_button type=”square” style=”filled” size=”small” align=”center” link=”https://www.frequencyfoundation.com/product/sv40-version-2-0/” popup=”no” top=”inherit” bottom=”inherit” left=”inherit” right=”inherit”]SV40 Frequencies[/trx_button]

Bookchin, D. and J. Schumacher (2004). The Virus and the Vaccine: The True Story of a Cancer-Causing Monkey Virus, Contaminated Polio Vaccine, and the Millions of Americans Exposed. New York, St. Martin’s Press.

Everyone infected with the SV40 virus should read this book and that includes at least 100 million Americans. The contamination of polio vaccine with the carcinogenic SV40 virus apparently continues even today in some cases. Information on the most carcinogenic of all viruses and its connection with polio vaccine has been systematically suppressed since the 1960’s. Careers have been threatened, some destroyed, others altered dramatically. Funding for investigating what will come to be known as one of the greatest public health problems of the 20th century is still severely restricted.

The authors original article in the Atlantic Monthly (Feb 2000) has been expanded into a riveting book that reads like a novel. Extensively documented, it includes a complete bibliography of all research on SV40 and notes from interviews of every major player in this controversy who is still alive. The story would make a great episode for the X-Files and you might never look at the NIH in quite the same way again. The 2004 controversy over NIH officials acting as consultants for the drug companies is only the tip of the iceberg.

Char Boehme published a set of frequencies on the Rifers list ([email protected]) developed from available DNA sequencing data. I have tested her frequencies against a known SV40 infection and they all test positive, demonstrating the value of DNA sequencing data and her technique. We both view this as a widespread public health problem generated by contaminated vaccines.

Parasites are often infected with SV40. When you kill them, they release more SV40. You may need to repeatedly clear your system of this virus after killing parasites. In addition, when killing cancer cells in SV40 induced tumors, the virus will be released and cause reinfection. Run SV40 frequencies after killing SV40 induced tumor cells. Finally, a magpulser will stimulate virus production in infected cells and this must be dealt with.

On review of the medical literature, there are clearly multiple forms of SV40. One mutated form cannot replicate and there are others. See:

Simian virus 40 (SV40) DNA replication: SV40 large T antigen unwinds DNA containing the SV40 origin of replication. Dean FB, Bullock P, Murakami Y, Wobbe CR, Weissbach L, Hurwitz J. Proc Natl Acad Sci U S A. 1987 Jan;84(1):16-20.

Complete nucleotide sequence of SV40 DNA.
Fiers W, Contreras R, Haegemann G, Rogiers R, Van de Voorde A, Van Heuverswyn H, Van Herreweghe J, Volckaert G, Ysebaert M. Nature. 1978 May 11;273(5658):113-20.

The determination of the total 5,224 base-pair DNA sequence of the virus SV40 has enabled us to locate precisely the known genes on the genome. At least 15.2% of the genome is presumably not translated into polypeptides. Particular points of interest revealed by the complete sequence are the initiation of the early t and T antigens at the same position and the fact that the T antigen is coded by two non-contiguous regions of the genome; the T antigen mRNA is spliced in the coding region. In the late region the gene for the major protein VP1 overlaps those for proteins VP2 and VP3 over 122 nucleotides but is read in a different frame. The almost complete amino acid sequences of the two early proteins as well as those of the late proteins have been deduced from the nucleotide sequence. The mRNAs for the latter three proteins are presumably spliced out of a common primary RNA transcript. The use of degenerate codons is decidedly non-random, but is similar for the early and late regions. Codons of the type NUC, NCG and CGN are absent or very rare.
______________________________________________

There is a new article out on the connection between cancer and the SV40 virus which is widely distributed in the human population because of polio vaccination contamination. NCI has followup studies on Army “volunteers” who were given contaminated polio vaccine in 1960-61.

Testing a volunteer (who was in the Army and given the vaccine in 1960) with a liver tumor and a history of melanoma and multiple basal cell carcinomas showed SV40 distributed throughout all organ systems. Plate zapping organ by organ was required to root it out.

I’ve noticed SV40 in several other cancer patients. Electronic medicine researchers should check each other for presence of this virus and eradicate it. SV40 causes cancer in lab animals, causes cells to become immortal in vitro, and is found in human tumors. It inactivates genes related to controlling cancerous growth. SV40 antibodies are present in 3-4% of the population. SV40 can start a tumor growing including cells that are not infected with HIV. The uninfected tumor cells have a selective growth advantage and replace infected cells, caused the SV40 virus to disappear. This stealth phenomena is one of the reasons it has been difficult to conclusively state that SV40 is causing cancer. However, for some tumors, the evidence is far stronger than smoking.

Simian virus 40 in human cancers
Regis A. Vilchez MD, Claudia A. Kozinetz PhD, MPH, Amy S. Arringtonc, Charles R. Madden PhD and Janet S. Butel PhD
The American Journal of Medicine Volume 114, Issue 8 , 1 June 2003, Pages 675-684

Abstract

Background
Many studies have reported the presence of simian virus 40 (SV40) deoxyribonucleic acid (DNA) or protein in human brain tumors and bone cancers, malignant mesothelioma, and non-Hodgkin’s lymphoma. However, the small samples and lack of control groups in some reports have made it difficult to assess their reliability.

Methods
Studies were included in this analysis if they met the following criteria: original studies of patients with primary brain tumors and bone cancers, malignant mesothelioma, or non-Hodgkin’s lymphoma; the investigation of SV40 was performed on primary cancer specimens; the analysis included a control group; and the same technique was used for cases and controls. Included reports were published from 1975 to 2002.

Results
Thirteen studies fulfilled the criteria for the investigation of primary brain cancers (661 tumors and 482 control samples). Specimens from patients with brain tumors were almost four times more likely to have evidence of SV40 infection than were those from controls (odds ratio [OR] = 3.9; 95% confidence interval [CI]: 2.6 to 5.8). The association was even stronger for mesothelioma (OR = 17; 95% CI: 10 to 28; based on 15 studies with 528 mesothelioma samples and 468 control samples) and for bone cancer (OR = 25; 95% CI: 6.8 to 88; based on four studies with 303 cancers and 121 control samples). SV40 DNA was also more frequent in samples from patients with non-Hodgkin’s lymphoma (OR = 5.4; 95% CI: 3.1 to 9.3; based on three studies with 301 cases and 578 control samples) than from controls.

Conclusion
These results establish that SV40 is associated significantly with brain tumors, bone cancers, malignant mesothelioma, and non-Hodgkin’s lymphoma. Studies are needed to assess current prevalence of SV40 infections.

http://dx.doi.org/10.1016/S0002-9343(03)00087-1

Nativis: Frequency Medicine Clinical Trial

Nativis science and technology is based on magnetically induced electron and charge transfer. Electron transfer is central to the function of many biologic processes and artificial magnetic fields are capable of triggering a receptor response and conformational change in the absence of a physical agonist. A specific and precise oscillating magnetic field with the proper vector, magnitude and pulse duration can move a charge along a protein pathway much the same way an electron is forced to move in copper wire. A charge moving between a donor and acceptor site in the presence of an oscillating magnetic field will result in a conformational dynamic similar to a naturally forced charge.

Non-Thermal Radio Frequency Stimulation of Tubulin Polymerization in Vitro: A Potential Therapy for Cancer Treatment
John T. Butters1, Xavier A. Figueroa2*, Bennett Michael Butters1 1 Nativis Inc., Seattle, WA, USA 2 Sciencia Incognita Consulting, LLC, Seattle, WA, USA

Copyright © 2014 by authors and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/

AbstractThe use of radio frequency energy is an established technology for certain oncology therapies. Direct inputs of radio frequency (RF) energy as thermal energy are applied to ablate tumors or catalyze secondary reactions in adjunct treatments against certain tumor types. Yet, other applications are being developed which take advantage of properties of RFs that impinge on biological proteins and cells without thermal effects. Here we report a proof-of-concept application of specific, digitally encoded, low power (non-thermal) radio frequency energy in an in vitro preparation of a tubulin polymerization assay. The radio frequency energy signal, designated M2(3), was applied to the tubulin polymerization assay samples during spectrophotometric measurements to assess the effectiveness for enhancing tubulin polymerization. A commercially available taxane (paclitaxel) that promotes tubulin polymerization was used as a control to assess the effectiveness of the M2(3) radio frequency energy signal on tubulin polymerization rates. A low power, specific, digital radio frequency energy signal is capable of promoting tubulin polymerization as effectively as a commercially available taxane.

GcMAF and Nagalase

[trx_video url=”https://www.youtube.com/watch?v=D1WZrnCcH24″ ratio=”16:9″ autoplay=”off” top=”inherit” bottom=”inherit” left=”inherit” right=”inherit”]

Always run Nagalase frequencies for viruses and cancer. Nagalase is directly proportional to tumor burden in cancer patients. Physicians recommend 10,000 units of Vitamin D a day to promote effects of GcMAF.
[trx_button type=”square” style=”filled” size=”small” align=”center” link=”https://www.frequencyfoundation.com/product/nagalase-version-2-4/” popup=”no” top=”inherit” bottom=”inherit” left=”inherit” right=”inherit”]Nagalase Frequencies[/trx_button]
Nagalase in Blood
Test for monitoring efficacy of therapy for cancer and certain viral infections

Nagalase in serum / plasma

The test measures the activity of an enzyme α-N-acetylgalactosaminidase (nagalase) in blood.

Nagalase is an extracellular matrix-degrading enzyme that is secreted by cancerous cells in the process of tumor invasion. It is also an intrinsic component of the envelope protein of various virions, such as HIV and the influenza virus. Thus, it is also secreted from virus-infected cells^1,3,4.

Nagalase deglycosylates the vitamin D3-binding protein DBP (also known as Gc-protein). Gc-protein, which contains three sugars, is the precursor for the major macrophage-activating factor (MAF). By complete deglycosylation, Gc-protein can no longer be converted to MAF.

Normally, MAF is produced from the Gc-protein by sequential removal of the galactose and sialic acid without touching the remaining sugar N-acetylgalactosamine.

Macrophage activation for phagocytosis and antigen presentation is the first step in the immune development cascade. Lost precursor activity, therefore, leads to immune suppression.

Increased nagalase activity has been detected in the blood of patients with a wide variety of cancers like cancer of the prostate, breast, colon, lung, esophagus, stomach, liver, pancreas, kidney, bladder, testis, uterus, and ovary, mesothelioma, melanoma, fibrosarcoma, glioblastoma, neuroblastoma, and various leukemias^1,3,4. For various types of tumors, various levels of nagalase activity were found⁷. It appears that the secretory capacity of individual tumor tissue varies among tumor types depending upon tumor size, staging, and the degree of malignancy or invasiveness⁷. Increased nagalase activity has not been detected in the blood of healthy individuals¹.

Nagalase activity is directly proportional to viable tumor burden^1,2. Studies correlating nagalase levels with tumor burden suggest that the measurement of this enzyme can diagnose the presence of cancerous lesions below levels detectable by other diagnostic means¹. In research studies, nagalase activity decreased to near tumor-free control levels one day after surgical removal of primary tumors from cancer patients, suggesting that the half-life of nagalase is less than 24 hours^1,6. The short half-life of nagalase is valuable for prognosis of the disease during various therapies^1,5. See HDRI …

Here is a frequency set which could be the most useful set in your arsenal. Tim Smith, M.D. reports:

How GcMAF works: GcMAF is the protein that activates macrophages and jump-starts the entire immune response. To sabotage the immune system and put the macrophages to sleep, all cancers and viruses make Nagalese, the enzyme that blocks production of GcMAF. In the absence of GcMAF, cancers, HIV, and other viruses can grow unimpeded. Dr. Nobuto Yamamoto demonstrated that GcMAF administration bypasses the Nagalese blockage and re-activates the macrophages, which then proceed to kill the cancer cells and HIV viruses.

All substances can be disrupted by frequencies. We don’t need GcMAF to bypass Nagalese. We can just eliminate the Nagalese. Running the program below yields a dramatic increase in immune response.

You will need to run the frequencies for several hours initially. Running them too much will start to make your energy low. The increase in immune function will cause your macrophages to attack cancer cells, viruses, and perhaps biofilms and other organisms. The immune response may make you feel worse in the short term. Better Health Guy gives a good rundown on his experience with this.

Appropriate candidates for GcMAF treatment include:

Cancer
Autoimmune diseases
Epstein-Barr Virus (EBV)
Hepatitis B virus (HBV)
Herpes Simplex virus (HSV)
Cystitis
Hepatitis C virus (HCV)
Multiple sclerosis (MS)
Urinary tract infection (UTI)
Autism Spectrum Disorders (ASD)
Rheumatoid arthritis (RA)
Endometriosis
Chronic Fatigue Syndrome (CFS)
Lyme disease (Lyme borreliosis)
IgA deficiency disorder
Myalgic Encephalomyelitis (ME)
Mycobacteria infections
Parkinson’s disease
Tuberculosis
Fibromyalgia
Human papillomavirus (HPV)
Lupus (Systemic lupus erythematosus, SLE)
HIV AIDS
Dengue fever
Pneumonia infection
Warts caused by viral infection
Norovirus
Malaria Influenza virus (flu)
Herpes simplex virus (HSV)
Q fever (Coxiella burnetii)
Polycystic ovary syndrome (PCOS)
Chicken pox (varicella zoster virus)
Psoriasis
Respiratory tract infections
Ulcerative colitis, Crohn’s disease
Type 1 diabetes (T1DM), insulin-dependent diabetes (IDDM)
Type 1.5 diabetes, Latent autoimmune diabetes of adults (LADA)

Learn more:

http://www.naturalnews.com/050972_GcMAF_cancer_cells_Bradstreet.html#ixzz3kMO73U00

https://www.naturalnews.com/050582_nagalase_GcMAF_cancer_industry_profits.html#

http://www.drgregorysmith.com/sermon/july-16th-2016-gcmaf-nagalese-and-60-holistic-doctors-dead-in-6-months-a-conversation-with-erin-elizabeth-on-truth-medicine-and-politics/

Frequencies are available for subscribers.

How Red Light Therapy Enhances Cellular Energy

The Connection: Red Light Therapy and the Warburg Effect

Real-world Applications of Red Light Therapy

Real-World Results and Practical Applications

How to Incorporate Red Light Therapy in Your Routine

Recommended Red Light Therapy Devices

Take Action Today for Your Health and Longevity

How Tumor Treating Fields Work

Redefining Survival with Complementary Treatment

The Power of Frequencies in Non-Invasive Treatment

A Future Fueled by Innovation

Linking with Frequency Research Foundation’s Innovations

Moms2B Avoid Fluoride

Why add fluoride to the list?

What should pregnant women know about this study?

Is there another mother-offspring study?

Is this new information?

Who funded these studies?

For more info on these studies use the links in the Select-a-Topic at the top

How is a pregnant woman exposed to fluoride?

What water should I drink if I am pregnant? — Find out here

Questions & Concerns? Check out the Q & A

Occasionally big pharma provides really useful results. Checking on which studies are valid by trying to replicate them in order to search for new drugs shows most published research is nonsense.

How Reliable Are Cancer Studies?

Chronic Periodontitis: Geographic Differences in the Oral Biofilm

Nagalase in serum / plasma

For more info on these studies use the links
in the Select-a-Topic at the top